hackint0sh/temp-data huggingface dataset:
protocolSection identificationModule nctId: NCT06318611, orgStudyIdInfo id: 09.2022.575, briefTitle: Sleep Patterns and Chronotype in Children With and Without Type 1 Diabetes, statusModule overallStatus: COMPLETED, startDateStruct date: 2022-05-01, primaryCompletionDateStruct date: 2023-05-01, completionDateStruct date: 2023-05-01, studyFirstPostDateStruct date: 2024-03-19, lastUpdatePostDateStruct date: 2024-03-19, sponsorCollaboratorsModule leadSponsor name: Koç University, class: OTHER, collaborators name: Marmara University, descriptionModule briefSummary: Type 1 diabetes (T1D) is one of the most common chronic childhood diseases. Recent studies have highlighted the strong association between type 1 diabetes and sleep health problems. Sleep problems have been reported to include sleep onset, sleep maintenance, frequent nighttime awakenings, and daytime sleepiness. Studies show that children with T1D sleep significantly less than their peers without diabetes, and that this is associated with poorer glycemic control in type 1 diabetes due to impaired glucose metabolism.This study aimed to compare sleep health composite dimensions and chronotype in children and adolescents with and without T1D, and to explore the relationship between sleep and glycemic variability in T1D.The study was designed as a prospective observational case-control study. The estimated sample size is calculated as 168.The sleep health composite dimensions were measured using actigraphy, sleep diaries, and self- or parental reports. Sleep disturbance will be assessed using the Diagnostic and Statistical Manual for Mental Disorders (DSM-5) Level 2-Sleep Disturbance Scale Short Form, and the Children's Chronotype Questionnaire will be used to determine the chronotype. Sleep/wake patterns were also assessed using sleep diaries. Glycemic variability was assessed using continuous glucose monitoring (CGM) device parameters., conditionsModule conditions: Type1diabetes, conditions: Sleep, conditions: Chronotype, designModule studyType: OBSERVATIONAL, designInfo observationalModel: CASE_CONTROL, timePerspective: PROSPECTIVE, enrollmentInfo count: 168, type: ACTUAL, armsInterventionsModule interventions name: sleep, chronotype, outcomesModule primaryOutcomes measure: Sleep health composite, primaryOutcomes measure: Chronotype, secondaryOutcomes measure: Glycemic variability, secondaryOutcomes measure: Glycemic control, eligibilityModule sex: ALL, minimumAge: 6 Years, maximumAge: 18 Years, stdAges: CHILD, stdAges: ADULT, contactsLocationsModule locations facility: Necla İpar, city: İstanbul, zip: 34010, country: Turkey, geoPoint lat: 41.01384, lon: 28.94966, hasResults: False
protocolSection identificationModule nctId: NCT06318598, orgStudyIdInfo id: 23M202, briefTitle: Biomarker-driven Phenotypic Dissection of Amyotrophic Lateral Sclerosis, acronym: DRIVEALS, statusModule overallStatus: RECRUITING, startDateStruct date: 2023-04-11, primaryCompletionDateStruct date: 2026-04-10, completionDateStruct date: 2026-04-10, studyFirstPostDateStruct date: 2024-03-19, lastUpdatePostDateStruct date: 2024-03-19, sponsorCollaboratorsModule leadSponsor name: Istituto Auxologico Italiano, class: OTHER, collaborators name: Azienda Ospedaliera Città della Salute e della Scienza di Torino, collaborators name: Ospedale San Raffaele, descriptionModule briefSummary: The goal of this observational study is to understand the clinical variability in a population of ALS patients using multidimensional biomarkers. The main questions it aims to answer are:* Which set of biomarkers explain genotypic-phenotypic correlations in ALS?* Which set of biomarkers can be used to subdivide the ALS population in homogeneous subgroups?Participants will undergo:* neurological evaluation* neurophysiological evaluation* neuropsychological evaluation* whole exome sequencing* biomarker measurement in CSF and plasma, conditionsModule conditions: Amyotrophic Lateral Sclerosis, conditions: Motor Neuron Disease, designModule studyType: OBSERVATIONAL, designInfo observationalModel: COHORT, timePerspective: PROSPECTIVE, enrollmentInfo count: 200, type: ESTIMATED, outcomesModule primaryOutcomes measure: genetic screening, primaryOutcomes measure: biomarker assessment, secondaryOutcomes measure: clinical assessment, secondaryOutcomes measure: neuropsychological assessment, eligibilityModule sex: ALL, minimumAge: 18 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Ospedale San Raffaele, status: RECRUITING, city: Milano, state: MI, zip: 20132, country: Italy, contacts name: Yuri Falzone, MD, PhD, role: CONTACT, geoPoint lat: 45.46427, lon: 9.18951, locations facility: Ospedale San Luca, status: RECRUITING, city: Milano, state: MI, zip: 20149, country: Italy, contacts name: Alberto Doretti, MD, role: CONTACT, phone: +0261911, phoneExt: 2937, email: a.doretti@auxologico.it, geoPoint lat: 45.46427, lon: 9.18951, locations facility: AOU Città della Salute e della Scienza, status: RECRUITING, city: Torino, state: TO, zip: 10126, country: Italy, contacts name: Adriano Chiò, MD, role: CONTACT, geoPoint lat: 45.07049, lon: 7.68682, hasResults: False
protocolSection identificationModule nctId: NCT06318585, orgStudyIdInfo id: 23C306, briefTitle: Creation of a Clinical Database for the Study of Phenotypic Variability in Motor Neuron Diseases, acronym: ALS-PHENO, statusModule overallStatus: RECRUITING, startDateStruct date: 2023-04-03, primaryCompletionDateStruct date: 2026-12-31, completionDateStruct date: 2026-12-31, studyFirstPostDateStruct date: 2024-03-19, lastUpdatePostDateStruct date: 2024-03-19, sponsorCollaboratorsModule leadSponsor name: Istituto Auxologico Italiano, class: OTHER, descriptionModule briefSummary: Study Description: Characterization of Motor Neuron Disease PhenotypesThe goal of this observational study is to understand the clinical presentation of motor neuron disease (MND) in patients attending the Neurology Department of the Istituto Auxologico Italiano. The main questions it aims to answer are:* What are the specific clinical phenotypes associated with MND?* How can these phenotypes contribute to a better understanding of the disease's underlying mechanisms and improve prognostic accuracy?Participants will undergo:* Clinical evaluation using validated scales* Neurophysiological and neuroradiological instrumental assessment* Neuropsychological evaluation* Collection of biological materials for genetic screening and biomarker assessment, if necessary., conditionsModule conditions: Amyotrophic Lateral Sclerosis, conditions: Motor Neuron Disease, designModule studyType: OBSERVATIONAL, designInfo observationalModel: COHORT, timePerspective: PROSPECTIVE, enrollmentInfo count: 200, type: ESTIMATED, outcomesModule primaryOutcomes measure: no. of patients with classic ALS, primaryOutcomes measure: no. of patients with bulbar ALS, primaryOutcomes measure: no. of patients with LMN phenotypes (flail arm, flail leg, PMA), primaryOutcomes measure: no. of patients with UMN phenotypes (pyramidal ALS, PLS), eligibilityModule sex: ALL, minimumAge: 18 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Ospedale San Luca, status: RECRUITING, city: Milano, state: MI, zip: 20149, country: Italy, contacts name: Alberto Doretti, MD, role: CONTACT, phone: +0261911, phoneExt: 2937, email: a.doretti@auxologico.it, geoPoint lat: 45.46427, lon: 9.18951, hasResults: False
protocolSection identificationModule nctId: NCT06318559, orgStudyIdInfo id: 027-FPO22, briefTitle: Artificial Intelligence 3D Augmented Reality Robot-Assisted-Radical- Prostatectomy v.s. no3D Intervention, acronym: RIDERS, statusModule overallStatus: RECRUITING, startDateStruct date: 2022-06-29, primaryCompletionDateStruct date: 2025-12-31, completionDateStruct date: 2027-12-31, studyFirstPostDateStruct date: 2024-03-19, lastUpdatePostDateStruct date: 2024-03-19, sponsorCollaboratorsModule leadSponsor name: Fondazione del Piemonte per l'Oncologia, class: OTHER, collaborators name: San Luigi Gonzaga Hospital, descriptionModule briefSummary: This is a prospective randomized multicenter study aimed at comparing 3D AI-AR-RARP vs. no 3D, verifying the impact of this new technology on oncological and functional outcomes after the procedure., conditionsModule conditions: Cancer of Prostate, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, interventionModelDescription: Patients will be randomized using an Excel® macro in 2 group: 3D and no3D, stratifying them by age, PSA, cT, PSA density, prostate volume, lesion volume, extracapsular extension (ECE), seminal vesicle invasion (SVI), biopsy ISUP., primaryPurpose: DIAGNOSTIC, maskingInfo masking: NONE, enrollmentInfo count: 120, type: ESTIMATED, armsInterventionsModule interventions name: 3D Robot-assisted laparoscopic radical prostatectomy and pelvic lymphadenectomy, outcomesModule primaryOutcomes measure: Perioperative surgical oncological outcomes, secondaryOutcomes measure: Micturition outcomes, secondaryOutcomes measure: Sexual function outcomes, secondaryOutcomes measure: Oncological outcomes, otherOutcomes measure: Verify the potential application of AI, eligibilityModule sex: MALE, minimumAge: 40 Years, maximumAge: 99 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Fondazione del Piemonte per l'Oncologia-IRCCS Candiolo, status: RECRUITING, city: Candiolo, state: Turin, zip: 10060, country: Italy, contacts name: Enrico Checcucci, MD, role: CONTACT, phone: +390119933632, email: enrico.checcucci@ircc.it, geoPoint lat: 44.95858, lon: 7.59812, locations facility: AOU san Luigi Gonzaga, status: RECRUITING, city: Orbassano, state: Turin, zip: 10060, country: Italy, contacts name: Francesco Porpiglia, MD, role: CONTACT, geoPoint lat: 45.00547, lon: 7.53813, hasResults: False
protocolSection identificationModule nctId: NCT06318546, orgStudyIdInfo id: FMASU MS59/2024, briefTitle: Dexmedetomidine in Spinal Anesthesia Decreasing Post Spinal Shivering in Caesarean Section, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-04-03, primaryCompletionDateStruct date: 2024-10, completionDateStruct date: 2024-11, studyFirstPostDateStruct date: 2024-03-19, lastUpdatePostDateStruct date: 2024-04-01, sponsorCollaboratorsModule leadSponsor name: Ain Shams University, class: OTHER, descriptionModule briefSummary: The investigators will test the effects of intrathecal dexmedetomidine as adjuvant to intrathecal bupivacaine and it's direct effect in decreasing incidence of post spinal shivering in Parturients Undergoing Caesarean section, conditionsModule conditions: Post Spinal Shivering, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: OTHER, maskingInfo masking: SINGLE, whoMasked: PARTICIPANT, enrollmentInfo count: 60, type: ESTIMATED, armsInterventionsModule interventions name: Dexmedetomidine Injection [Precedex],,,, interventions name: Fentanyl, outcomesModule primaryOutcomes measure: Post spinal shivering, eligibilityModule sex: FEMALE, minimumAge: 20 Years, maximumAge: 35 Years, stdAges: ADULT, hasResults: False
protocolSection identificationModule nctId: NCT06318533, orgStudyIdInfo id: 2023-11-01, briefTitle: A Clinical Study of CD19 CAR NK Cells for the Treatment of Relapsed/Refractory B-cell Related Autoimmune Diseases, statusModule overallStatus: RECRUITING, startDateStruct date: 2024-03-13, primaryCompletionDateStruct date: 2025-03-13, completionDateStruct date: 2026-03-13, studyFirstPostDateStruct date: 2024-03-19, lastUpdatePostDateStruct date: 2024-03-25, sponsorCollaboratorsModule leadSponsor name: YANRU WANG, class: OTHER, collaborators name: Rui Therapeutics Co., Ltd, descriptionModule briefSummary: A single arm, open-label pilot study is designed to determine the safety and effectiveness of anti-CD19 CAR NK cells (KN5501) in patients with relapsed/refractory B-cell related autoimmune diseases.15 patients are planned to be enrolled in the dose-escalation trial (6×10\^9 cells, 9×10\^9 cells). The primary objective of the study is to evaluation of the safety and feasibility of KN5501 for the treatment of relapsed/refractory B-cell related autoimmune diseases. The secondary objective is to evaluate the effectiveness of KN5501 for the treatment of relapsed/refractory B-cell related autoimmune diseases. The exploratory objective is to evaluate expansion, persistence and ability to deplete CD19 positive B cells of KN5501 in patients with relapsed/refractory B-cell related autoimmune diseases., conditionsModule conditions: Autoimmune Diseases, designModule studyType: INTERVENTIONAL, phases: EARLY_PHASE1, designInfo allocation: NA, interventionModel: SINGLE_GROUP, primaryPurpose: TREATMENT, maskingInfo masking: NONE, enrollmentInfo count: 15, type: ESTIMATED, armsInterventionsModule interventions name: anti-CD19 CAR NK cells, outcomesModule primaryOutcomes measure: Incidence of Dose Limiting Toxicity (DLTs), primaryOutcomes measure: Treatment Emergent Adverse Events（TEAEs）, secondaryOutcomes measure: Disease control rate of subjects, secondaryOutcomes measure: Remission rate of subjects, eligibilityModule sex: ALL, minimumAge: 18 Years, maximumAge: 70 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Affiliated Hospital of Jiangsu University, status: RECRUITING, city: Zhenjiang, state: Jiangsu, zip: 212001, country: China, contacts name: Yu Tang, role: CONTACT, phone: 086-13815153350, email: tangtang@ujs.edu, contacts name: Yu Tang, Dr., role: PRINCIPAL_INVESTIGATOR, geoPoint lat: 32.21086, lon: 119.45508, locations facility: Jiangsu University Affiliated Hospital, status: RECRUITING, city: Zhenjiang, state: Jiangsu, zip: 212001, country: China, contacts name: Yanru Wang, role: CONTACT, phone: 0511-85026079, email: tangtang@ujs.edu, contacts name: Yu Tang, Doctor, role: PRINCIPAL_INVESTIGATOR, geoPoint lat: 32.21086, lon: 119.45508, hasResults: False
protocolSection identificationModule nctId: NCT06318520, orgStudyIdInfo id: AFSU-DHF-TOPAL-001, briefTitle: Clinical Success of Stainless Steel Crowns Applied Using Different Cements, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-04-01, primaryCompletionDateStruct date: 2025-04-01, completionDateStruct date: 2025-05-01, studyFirstPostDateStruct date: 2024-03-19, lastUpdatePostDateStruct date: 2024-03-20, sponsorCollaboratorsModule leadSponsor name: Afyonkarahisar Health Sciences University, class: OTHER, descriptionModule briefSummary: The main question of the study was to evaluate the one-year clinical success of SSc bonded with two different cement types in MIH teeth with excessive material loss. The researchears will compare the survival rate, effect on gingival health and radiographic success of calcium silicate-based resin-containing cement and resin-modified glass ionomer cement., conditionsModule conditions: Dental Enamel Hypomineralization, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: TREATMENT, maskingInfo masking: TRIPLE, whoMasked: PARTICIPANT, whoMasked: INVESTIGATOR, whoMasked: OUTCOMES_ASSESSOR, enrollmentInfo count: 20, type: ESTIMATED, armsInterventionsModule interventions name: Use of Calcium silicate based resin cement and resin modified glass ionomer cement, outcomesModule primaryOutcomes measure: Anatomical Integrity, primaryOutcomes measure: Marginal Compliance, primaryOutcomes measure: Proximal Contact, primaryOutcomes measure: Crown Marginal Location, primaryOutcomes measure: Restoration success, primaryOutcomes measure: Green and Vermillion's Oral Hygiene Index, secondaryOutcomes measure: Marginal Fit of the Crown (RADIOLOGICAL), eligibilityModule sex: ALL, minimumAge: 9 Years, maximumAge: 12 Years, stdAges: CHILD, contactsLocationsModule locations facility: Afyonkarahisar Health Sciences University, city: Afyonkarahisar, zip: 03030, country: Turkey, contacts name: Burcu GUCYETMEZ TOPAL, Asst.Prof, role: CONTACT, phone: +90 530 281 35 85, email: dt.burcugucyetmez@hotmail.com, contacts name: Esma ATIS, Res.Ass., role: SUB_INVESTIGATOR, geoPoint lat: 38.75667, lon: 30.54333, hasResults: False
protocolSection identificationModule nctId: NCT06318507, orgStudyIdInfo id: PBRC 2023-014, briefTitle: The Intestinal Microbiome in Triple Negative Breast Cancer Treated With Immunotherapy, acronym: IMPACT, statusModule overallStatus: RECRUITING, startDateStruct date: 2024-03-11, primaryCompletionDateStruct date: 2024-12-31, completionDateStruct date: 2025-12-31, studyFirstPostDateStruct date: 2024-03-19, lastUpdatePostDateStruct date: 2024-03-19, sponsorCollaboratorsModule leadSponsor name: Pennington Biomedical Research Center, class: OTHER, descriptionModule briefSummary: This study will determine how the intestinal microbiome differs between patients with obesity and early triple-negative breast cancer who achieve a pathologic complete response from preoperative anti-PD-1 immunotherapy (pembrolizumab) versus patients who do not., conditionsModule conditions: Breast Neoplasms, designModule studyType: OBSERVATIONAL, designInfo observationalModel: CASE_ONLY, timePerspective: PROSPECTIVE, enrollmentInfo count: 25, type: ESTIMATED, armsInterventionsModule interventions name: Fecal microbial diversity, outcomesModule primaryOutcomes measure: Pathologic Complete Response (pCR), eligibilityModule sex: FEMALE, minimumAge: 18 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Pennington Biomedical Research Center, status: RECRUITING, city: Baton Rouge, state: Louisiana, zip: 70808, country: United States, contacts name: Justin Brown, Ph.D., role: CONTACT, phone: 225-763-2715, email: justin.brown@pbrc.edu, geoPoint lat: 30.45075, lon: -91.15455, hasResults: False
protocolSection identificationModule nctId: NCT06318494, orgStudyIdInfo id: Ankle-optogait, briefTitle: Analysis of Jumping in Patients With Ankle Instability (Ankle-optogait), acronym: Ankle-optoga, statusModule overallStatus: ACTIVE_NOT_RECRUITING, startDateStruct date: 2022-04-28, primaryCompletionDateStruct date: 2025-01, completionDateStruct date: 2025-07, studyFirstPostDateStruct date: 2024-03-19, lastUpdatePostDateStruct date: 2024-03-19, sponsorCollaboratorsModule leadSponsor name: I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio, class: OTHER, descriptionModule briefSummary: The study is, in accordance with current legislation, definable as a single-center interventional study with evaluations carried out at a single timeframe.The objective of the study is to compare jumping performance between subjects with ankle instability and healthy volunteer subjects.In particular, the primary objective is to verify the difference in the monopodalic CMJ value of the diseased limb of subjects with ankle instability compared to the control group at time 0.The population is made up of patients suffering from ankle instability and a control group of healthy volunteers, divided as follows:25 subjects GROUP A: Study group: patients suffering from ankle instability25 subjects GROUP B: control group: healthy voluntary subjects not affected by ankle pathology, conditionsModule conditions: Ankle Disease, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: NON_RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: OTHER, maskingInfo masking: NONE, enrollmentInfo count: 50, type: ESTIMATED, armsInterventionsModule interventions name: jumping performance, outcomesModule primaryOutcomes measure: verify the difference in the monopodalic CMJ (countermovement jump test) of the diseased limb of subjects with ankle instability compared to the control group, eligibilityModule sex: ALL, minimumAge: 18 Years, maximumAge: 45 Years, stdAges: ADULT, contactsLocationsModule locations facility: Istituto Clinico San Siro, city: Milan, country: Italy, geoPoint lat: 45.46427, lon: 9.18951, hasResults: False
protocolSection identificationModule nctId: NCT06318481, orgStudyIdInfo id: IRB-80/2023, briefTitle: TADCLOT- a Double Blind Randomized Controlled Trial, acronym: TADCLOT, statusModule overallStatus: RECRUITING, startDateStruct date: 2024-02-15, primaryCompletionDateStruct date: 2024-11-15, completionDateStruct date: 2024-12-15, studyFirstPostDateStruct date: 2024-03-19, lastUpdatePostDateStruct date: 2024-03-19, sponsorCollaboratorsModule leadSponsor name: National Institute of Cardiovascular Diseases, Pakistan, class: OTHER, collaborators name: PharmEvo Pvt Ltd, descriptionModule briefSummary: Compare the safety and efficacy of a twice-daily Clopidogrel regimen vs. Ticagrelor in reducing major adverse events in patients undergoing primary PCI in a double-blind randomized controlled trial., conditionsModule conditions: Stent Thrombosis, conditions: Myocardial Infarction, Acute, designModule studyType: INTERVENTIONAL, phases: PHASE3, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: TREATMENT, maskingInfo masking: TRIPLE, maskingDescription: Care provider and investigator are same so both are blinded in the trial., whoMasked: PARTICIPANT, whoMasked: CARE_PROVIDER, whoMasked: INVESTIGATOR, enrollmentInfo count: 2200, type: ESTIMATED, armsInterventionsModule interventions name: Ticagrelor 90 MG, interventions name: Clopidogrel, outcomesModule primaryOutcomes measure: Evaluation of efficacy and safety, secondaryOutcomes measure: Secondary endpoint, eligibilityModule sex: ALL, minimumAge: 18 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: National Institute of Cardiovascular Diseases, status: RECRUITING, city: Karachi, state: SIndh, zip: 755000, country: Pakistan, contacts name: Abdul Hakeem, MD, role: CONTACT, phone: 6086953048, email: ahakeem@gmail.com, contacts name: Jehangir Shah, MBBS, role: CONTACT, email: jehangirshah91@gmail.com, geoPoint lat: 24.8608, lon: 67.0104, hasResults: False
protocolSection identificationModule nctId: NCT06318468, orgStudyIdInfo id: N202306106, briefTitle: The Effectiveness of Various Teaching Methods to Enhance the Comprehensive Nursing Assessment Skills of New Nurses, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-04, primaryCompletionDateStruct date: 2024-10-31, completionDateStruct date: 2024-10-31, studyFirstPostDateStruct date: 2024-03-19, lastUpdatePostDateStruct date: 2024-03-19, sponsorCollaboratorsModule leadSponsor name: Taipei Medical University WanFang Hospital, class: OTHER, descriptionModule briefSummary: This study is going to compare different teaching strategies for improving newly recruited nurses' comprehensive nursing assessment skills., conditionsModule conditions: Competence, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: OTHER, maskingInfo masking: SINGLE, whoMasked: OUTCOMES_ASSESSOR, enrollmentInfo count: 80, type: ESTIMATED, armsInterventionsModule interventions name: Nursing health assessment teaching and discussion using humanoid diagrams, interventions name: Nursing health assessment teaching and discussion using case study, outcomesModule primaryOutcomes measure: Comprehensive health assessment questionnaire, primaryOutcomes measure: Comprehensive health assessment questionnaire, primaryOutcomes measure: Comprehensive health assessment questionnaire, primaryOutcomes measure: Confidence scale (C-scale), primaryOutcomes measure: Confidence scale (C-scale), primaryOutcomes measure: Confidence scale (C-scale), secondaryOutcomes measure: Course satisfaction questionnaire, eligibilityModule sex: ALL, minimumAge: 18 Years, maximumAge: 65 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Taipei Medical University WanFang Hospital, city: Taipei, country: Taiwan, contacts name: Mei Fen Tang, master, role: CONTACT, phone: 0970746226, email: 5053@w.tmu.edu.tw, geoPoint lat: 25.04776, lon: 121.53185, hasResults: False